• Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Log in to your Inderes Free account to see all free content on this page.
Create account

Revenio Group

12.52 EUR

0.00 %

14,373 following

REG1V

NASDAQ Helsinki

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
0.00 %
-11.08 %
-31.13 %
-44.11 %
-43.22 %
-54.06 %
-61.33 %
-79.37 %
+558.95 %

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Read more
Market cap
365.17M EUR
Turnover
292.7K EUR
P/E (adj.) (26e)
EV/EBIT (adj.) (26e)
P/B (26e)
EV/S (26e)
Dividend yield-% (26e)
Coverage
Recommendation
Buy
Target price
Updated
29.04.2026
Disclaimer
Revenue and EBIT-%
EPS and dividend
Financial calendar
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types

Forum discussions
I promised to write a bit about yesterday’s meeting with Revenio’s CEO Jouni Toijala, so here are some of my scattered thoughts. We had about 2.5 hours and there were around 40 fellow investors, so questions ranged from the new acquisition and distribution network to specific questions...
6/17/2026, 8:00 AM
by Pandakarhu
85
Thank you @Pandakarhu for the comprehensive answer and for sharing the information Apologies for my skepticism and for harping on these points, but we are dealing with major issues regarding the Revenio investment case. I have nothing against inorganic expansion. Visionix’s offering...
6/17/2026, 10:25 AM
by Ummon
32
The brands are indeed all over the place, but on a positive note, there is very little overlap in the products; now they just really need to figure out how to brand this entity. In my opinion, however, the acquisition is quite fresh and it’s quite normal that management is currently...
6/17/2026, 10:56 AM
by Pandakarhu
29
The CEO’s view is likely based on this: According to the CEO, American investors have remained significantly more confident than Europeans. “If we consider our shareholder base, the Americans have remained very confident.” According to Toijala, this is also evident in investor meetings...
6/17/2026, 6:27 AM
by NukkeNukuttaja
15
Midsummer provided an opportunity for some quiet reflection. From Revenio’s perspective, what is significant is perhaps not so much capturing territory with current technology, but rather being part of the flow in the direction the industry is heading and noticing what competitors...
16 hours ago
by Sissos
14
I didn’t quite understand how the EBITDA improvement will be achieved either. In addition, some information regarding the share issues: the directed share issue has already been carried out at a high subscription price. The public offering is expected around the beginning of October...
6/17/2026, 9:50 AM
by Sergio
11
To me, it is crystal clear what the profitability improvement calculations are based on. Whether it will be easy and whether it will materialize to the extent planned is a different matter. In a nutshell: phase out in-house sales staff as much as possible and provide distributors...
6/17/2026, 3:03 PM
by Teletappi
9
Read more on our forum
Juha Kinnunen
Juha Kinnunen

Analyst

Latest research

Latest analysis report

Released: 29.04.2026

Latest extensive report

Released: 21.01.2025

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
8.9.
2026

Interim report Q2'26

11.11.
2026

Interim report Q3'26

Regulatory press release6/12/2026, 7:00 AM

Revenio Group Corporation: Managers' Transactions – Marc Abitbol Consulting Service Ltd.

Revenio Group
Regulatory press release6/11/2026, 9:20 AM

Correction: Changes to the publication dates of Revenio’s financial reports in 2026

Revenio Group
Regulatory press release6/10/2026, 4:00 PM

Changes to the publication dates of Revenio’s financial reports in 2026

Revenio Group

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Regulatory press release6/10/2026, 4:00 PM

Board of Directors of Revenio has established Technology and Integration Committees

Revenio Group
Regulatory press release6/2/2026, 7:00 AM

Revenio Group Corporation: Managers' Transactions – Marc Abitbol

Revenio Group
Regulatory press release6/2/2026, 7:00 AM

Revenio Group Corporation: Managers' Transactions – Caravelle Capital SAS

Revenio Group
Regulatory press release5/29/2026, 1:00 PM

Notification of change in holdings according to Chapter 9, Section 10 of the Finnish Securities Market Act

Revenio Group
Regulatory press release5/29/2026, 6:45 AM

New shares issued in Revenio’s directed share issue have been registered with the Finnish Trade Register

Revenio Group
Revenio: Visionix acquisition completed slightly faster than expected
Analyst Comment5/29/2026, 6:59 AM by
Juha Kinnunen

Revenio: Visionix acquisition completed slightly faster than expected

The slightly faster-than-expected closing of the Visionix transaction mechanically raises this year's revenue and earnings estimates.

Revenio Group
Regulatory press release5/28/2026, 10:34 AM

Revenio introduces new Leadership Team following the completion of the Visionix transaction

Revenio Group
Regulatory press release5/28/2026, 10:32 AM

Changes in the Board of Directors of Revenio

Revenio Group
Regulatory press release5/28/2026, 10:30 AM

Revenio completes the acquisition of Visionix and has resolved on a directed share issue as part of the purchase price payment

Revenio Group
Regulatory press release5/13/2026, 3:30 PM

Jukka Kainulainen appointed CFO and member of the Leadership Team of Revenio Group

Revenio Group
Regulatory press release5/12/2026, 3:15 PM

Resolutions of Revenio Group Corporation's Annual General Meeting and the organizing meeting of the Board of Directors

Revenio Group
Revenio Q1'26: Buy and be patient
Research4/29/2026, 6:31 AM by
Juha Kinnunen

Revenio Q1'26: Buy and be patient

The market's disbelief regarding the Visionix acquisition offers an exceptionally good expected return for the coming years.

Revenio Group
Revenio Interim Report Q1/2026
Webcast4/28/2026, 12:00 PM

Revenio Interim Report Q1/2026

Revenio Group
Regulatory press release4/28/2026, 6:00 AM

Revenio Group Corporation: Interim Report January 1 – March 31, 2026

Revenio Group
Revenio Q1'26 preview: Visionix elevates Revenio to the big leagues
Research4/24/2026, 9:40 AM by
Juha Kinnunen

Revenio Q1'26 preview: Visionix elevates Revenio to the big leagues

Visionix elevates Revenio to the big leagues, but before that, a challenging 18-month integration period lies ahead. We have updated our forecasts to reflect the new entity that will be formed during the summer.

Revenio Group
Press release4/23/2026, 11:30 AM

Modular Finance IR Consensus: Revenio Group – Consensus estimates Q1 2026

Revenio Group
Press release4/17/2026, 6:00 AM

Revenio’s Interim report January-March 2026 to be published on April 28, 2026

Revenio Group